Previous 10 | Next 10 |
2023-12-20 23:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-19 10:22:30 ET Summary Organon's stock has declined 32% since September, making it one of the worst performers in healthcare. The company reported mixed financial results, with 1% growth in product sales and a decline in total revenue. Organon's biggest challenge is de...
Organon becomes the sole distributor and promoter of Emgality ® ( galcanezumab) and RAYVOW ™ (lasmiditan) in Europe, building on strong commercial expertise in central nervous system disorders Expands Organon’s European product portfolio in a...
2023-12-15 09:45:07 ET United States Steel Corp. (X) X is trading UP for the last 5 days, and it at trading at $39.20 with volume of 3,114,701 and a one day change of $0.34 (0.86%). United States Steel Corp. has a 52-week low of 20.68 and a 52-week high of $35.03. The business's 50-...
2023-12-12 11:07:43 ET Summary Investors should consider tax-loss selling before December ends to offset capital gains. Two characteristics to consider for selling stocks are stocks bought at a higher price and broken companies with weak long-term prospects. Stock grades, sent...
2023-12-01 11:11:51 ET More on Kenvue, Organon, etc. Organon: It's Darkest Before The Dawn Organon & Co (OGN) Piper Sandler 35th Annual Healthcare Conference (Transcript) Kenvue: Dude, Where's My Dividend Growth? Kenvue may be activist target amid recent ...
2023-11-30 02:52:19 ET Summary Organon is a global healthcare company focused on women's health, with a diverse portfolio of prescription therapies and medical devices. OGN stock has been on a downward trend due to declining sales and excessive debt on the balance sheet. Despi...
2023-11-29 12:45:25 ET Organon & Co (OGN) Piper Sandler 35th Annual Healthcare Conference November 29, 2023 11:00 AM ET Company Participants Kevin Ali - Chief Executive Officer Matthew Walsh - Chief Financial Officer Conference Call Participants David...
2023-11-21 13:48:38 ET Summary VTRS reported Q3-2023 earnings in line with estimates, with total sales down 3.3%. Adjusted EBITDA fell again, and new product launches are not delivering the same margins as the old business. We look at the progress made since its listing and te...
2023-11-21 09:53:36 ET A dividend yield can tell you a lot about a payout. Not only does it tell you how much you could be collecting in dividend income, but it can give you an indication of investor sentiment, and whether the stock struggles or is doing well. An excessively high yield, for...
News, Short Squeeze, Breakout and More Instantly...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...
Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the marketing authorization applications (MAAs) for HLX14, an investigational Prolia ® and Xgeva ® (denosumab) biosimilar. Denosumab has been a...
2024-05-23 02:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...